Overview
Role of Andi-d in Dengue Fever: a Pilot Study
Status:
Completed
Completed
Trial end date:
2011-09-01
2011-09-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is evaluate the role of anti-d in dengue fever.Phase:
N/AAccepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Postgraduate Institute of Medical Education and ResearchTreatments:
gamma-Globulins
Immunoglobulins, Intravenous
Rho(D) Immune Globulin
Criteria
inclusion criteria:- fever and thrombocytopenia with/without bleeding manifestations
- dengue serology positive patients
- platelet count ≤ 20,000/mm3
- Rh positive patients
- willing to give written informed consent
exclusion criteria:
- dengue serology positive but platelet count > 20,000/mm3
- Rh negative patients
- pregnant females